EPS for Bank of Hawaii (BOH) Expected At $1.09; 683 Capital Management Has Cut Its Alnylam Pharmaceuticals (ALNY) Stake

January 14, 2018 - By Richard Conner

683 Capital Management Llc decreased Alnylam Pharmaceuticals Inc (ALNY) stake by 11.3% reported in 2017Q3 SEC filing. 683 Capital Management Llc sold 30,500 shares as Alnylam Pharmaceuticals Inc (ALNY)’s stock rose 48.45%. The 683 Capital Management Llc holds 239,500 shares with $28.14 million value, down from 270,000 last quarter. Alnylam Pharmaceuticals Inc now has $12.80B valuation. The stock increased 0.80% or $1.02 during the last trading session, reaching $129.07. About 796,481 shares traded. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has risen 33.54% since January 14, 2017 and is uptrending. It has outperformed by 16.84% the S&P500.

Analysts expect Bank of Hawaii Corporation (NYSE:BOH) to report $1.09 EPS on January, 22.They anticipate $0.07 EPS change or 6.86% from last quarter’s $1.02 EPS. BOH’s profit would be $46.30 million giving it 20.33 P/E if the $1.09 EPS is correct. After having $1.08 EPS previously, Bank of Hawaii Corporation’s analysts see 0.93% EPS growth. The stock increased 0.85% or $0.75 during the last trading session, reaching $88.62. About 204,531 shares traded or 13.93% up from the average. Bank of Hawaii Corporation (NYSE:BOH) has risen 13.94% since January 14, 2017 and is uptrending. It has underperformed by 2.76% the S&P500.

Since September 20, 2017, it had 0 insider buys, and 3 selling transactions for $23.18 million activity. Mason Michael sold $4.84M worth of stock or 36,745 shares. On Monday, October 2 Greene Barry E sold $10.66 million worth of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) or 85,316 shares.

Investors sentiment decreased to 0.92 in Q3 2017. Its down 0.60, from 1.52 in 2017Q2. It is negative, as 30 investors sold ALNY shares while 73 reduced holdings. 40 funds opened positions while 55 raised stakes. 86.02 million shares or 0.72% more from 85.40 million shares in 2017Q2 were reported. Kornitzer Capital Mngmt Ks accumulated 162,835 shares or 0.33% of the stock. Jefferies Group Lc stated it has 12,500 shares or 0.01% of all its holdings. Segall Bryant And Hamill has 2,000 shares. 59,860 are owned by Dekabank Deutsche Girozentrale. Morgan Stanley invested 0.03% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Moreover, Swiss Savings Bank has 0.02% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Northern holds 376,728 shares. Ww Asset Management Incorporated accumulated 3,485 shares. Millennium Management Ltd Liability reported 51,125 shares. Parallax Volatility Advisers Lp holds 0.01% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) or 45,390 shares. Blue Ridge Capital reported 3.23% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). The Georgia-based Voya Inv Mngmt Limited Liability has invested 0.01% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Fic Cap holds 6.74% or 150,676 shares. Tortoise Inv Ltd Com holds 198 shares. Putnam Investments Limited Liability Company holds 0.04% or 134,572 shares in its portfolio.

Analysts await Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) to report earnings on February, 14. They expect $-1.40 earnings per share, down 6.06% or $0.08 from last year’s $-1.32 per share. After $-1.34 actual earnings per share reported by Alnylam Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 4.48% negative EPS growth.

683 Capital Management Llc increased Procter And Gamble Co (Put) (NYSE:PG) stake by 100,000 shares to 300,000 valued at $27.29 million in 2017Q3. It also upped Zafgen Inc (NASDAQ:ZFGN) stake by 101,600 shares and now owns 1.30 million shares. North Atlantic Drilling Ltd was raised too.

Among 23 analysts covering Alnylam Pharmaceuticals (NASDAQ:ALNY), 17 have Buy rating, 1 Sell and 5 Hold. Therefore 74% are positive. Alnylam Pharmaceuticals has $220 highest and $34 lowest target. $120.57’s average target is -6.59% below currents $129.07 stock price. Alnylam Pharmaceuticals had 89 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Janney Capital on Thursday, September 29. The stock has “Buy” rating by Jefferies on Friday, August 5. The rating was maintained by Leerink Swann on Tuesday, May 3 with “Outperform”. The firm has “Buy” rating given on Thursday, August 10 by BMO Capital Markets. Needham maintained it with “Buy” rating and $9800 target in Monday, July 10 report. The rating was maintained by Stifel Nicolaus on Thursday, October 6 with “Hold”. Piper Jaffray maintained it with “Buy” rating and $182.0 target in Sunday, January 7 report. Jefferies maintained the stock with “Buy” rating in Monday, January 8 report. Chardan Capital Markets maintained Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on Wednesday, November 30 with “Buy” rating. Leerink Swann maintained Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on Tuesday, February 16 with “Outperform” rating.

Among 10 analysts covering Bank of Hawaii (NYSE:BOH), 1 have Buy rating, 1 Sell and 8 Hold. Therefore 10% are positive. Bank of Hawaii has $9400 highest and $61 lowest target. $80.28’s average target is -9.41% below currents $88.62 stock price. Bank of Hawaii had 25 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Monday, January 8 by Jefferies. The firm has “Neutral” rating by Piper Jaffray given on Friday, July 8. The firm earned “Neutral” rating on Tuesday, April 26 by Macquarie Research. The firm earned “Neutral” rating on Thursday, August 11 by Compass Point. On Monday, July 24 the stock rating was maintained by Piper Jaffray with “Hold”. The stock of Bank of Hawaii Corporation (NYSE:BOH) has “Hold” rating given on Friday, September 22 by Keefe Bruyette & Woods. As per Monday, October 23, the company rating was maintained by Piper Jaffray. The rating was maintained by RBC Capital Markets with “Sector Perform” on Tuesday, January 26. The firm earned “Hold” rating on Monday, August 14 by Keefe Bruyette & Woods. The firm has “Equal Weight” rating given on Tuesday, October 25 by Barclays Capital.

Since September 5, 2017, it had 0 insider buys, and 2 insider sales for $552,386 activity. The insider TANOUE DONNA A sold 1,185 shares worth $91,079.

Investors sentiment increased to 1.25 in Q3 2017. Its up 0.29, from 0.96 in 2017Q2. It increased, as 14 investors sold Bank of Hawaii Corporation shares while 74 reduced holdings. 32 funds opened positions while 78 raised stakes. 31.76 million shares or 1.65% less from 32.29 million shares in 2017Q2 were reported. Geode Capital Management Limited Liability Corporation accumulated 0.01% or 359,229 shares. Pinebridge Invests Limited Partnership holds 23,024 shares or 0.05% of its portfolio. Cambridge Rech Advsr Incorporated accumulated 4,572 shares. Kayne Anderson Rudnick Inv Ltd Liability Com reported 0.93% in Bank of Hawaii Corporation (NYSE:BOH). Morgan Stanley invested 0% of its portfolio in Bank of Hawaii Corporation (NYSE:BOH). Tdam Usa Incorporated invested in 0.11% or 21,993 shares. Payden Rygel stated it has 1.33% of its portfolio in Bank of Hawaii Corporation (NYSE:BOH). Whittier Trust holds 0.03% in Bank of Hawaii Corporation (NYSE:BOH) or 8,676 shares. Parametric Port Associates stated it has 0.01% of its portfolio in Bank of Hawaii Corporation (NYSE:BOH). Bb&T holds 0.06% or 38,999 shares in its portfolio. Community Savings Bank Na owns 100 shares for 0% of their portfolio. Louisiana State Employees Retirement Sys accumulated 0.04% or 11,400 shares. 403,178 are held by Btim. First State Bank holds 0.22% or 34,595 shares in its portfolio. Marble Harbor Invest Counsel Lc holds 113,850 shares.

Bank of Hawaii Corporation operates as the holding firm for Bank of Hawaii that provides financial services and products in Hawaii, Guam, and other Pacific Islands. The company has market cap of $3.76 billion. The firm operates through four divisions: Retail Banking, Commercial Banking, Investment Services, and Treasury and Other. It has a 20.42 P/E ratio. The Retail Banking segment offers financial services and products to clients and small businesses.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>